EOLS: Evolus, Inc.
About
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Current Value
$12.361 Year Return
Current Value
$12.361 Year Return
Key Details
Market Cap
$784.55M
P/E Ratio
-13.55
1Y Stock Return
31.53%
1Y Revenue Growth
34.43%
Dividend Yield
0.00%
Price to Book
133.1
Strategies that include EOLS
Stock's related to EOLS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PLRX | 34.60% | $778.32M | -9.55% | 0.00% |
| OLO | 32.56% | $1.06B | +30.00% | 0.00% |
| KIDS | 31.46% | $588.93M | -24.59% | 0.00% |
| APPS | 29.36% | $125.51M | -75.85% | 0.00% |
| CWAN | 28.70% | $6.77B | +47.68% | 0.00% |
| CXM | 27.51% | $1.97B | -48.51% | 0.00% |
| GPRO | 27.44% | $179.52M | -67.23% | 0.00% |
| PWP | 27.41% | $1.45B | +124.87% | 1.11% |
| ALTO | 27.24% | $106.54M | -39.83% | 0.00% |
| ANAB | 27.16% | $607.66M | +40.93% | 0.00% |
| SBGI | 27.12% | $1.09B | +17.36% | 6.11% |
| KELYA | 27.01% | $504.23M | -32.54% | 2.14% |
| ATRO | 26.92% | $575.48M | +5.29% | 0.00% |
| DVA | 26.77% | $12.87B | +60.92% | 0.00% |
| REXR | 26.58% | $9.55B | -8.36% | 3.81% |
| GDRX | 26.54% | $1.62B | -24.15% | 0.00% |
| TRC | 26.47% | $424.34M | -2.47% | 0.00% |
| LZ | 26.40% | $1.30B | -33.57% | 0.00% |
| TSE | 26.35% | $117.53M | -50.37% | 1.20% |
| PRO | 26.33% | $1.05B | -39.43% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CDW | 0.07% | $23.19B | -19.73% | 1.42% |
| TRIN | -0.09% | $842.35M | -3.18% | 14.19% |
| GES | -0.09% | $851.55M | -23.98% | 7.30% |
| CNA | 0.11% | $13.16B | +23.03% | 3.61% |
| E | -0.13% | $46.24B | -10.80% | 9.02% |
| PPC | 0.13% | $12.38B | +100.96% | 0.00% |
| MYRG | 0.13% | $2.35B | +19.41% | 0.00% |
| CACC | -0.19% | $5.39B | +4.23% | 0.00% |
| NOG | 0.22% | $4.10B | +9.43% | 3.97% |
| NWG | 0.22% | $41.67B | +93.64% | 4.45% |
| HP | 0.22% | $3.30B | -10.93% | 3.02% |
| WTTR | 0.24% | $1.45B | +92.87% | 1.78% |
| PRPO | -0.25% | $9.10M | -13.65% | 0.00% |
| RES | 0.25% | $1.26B | -20.54% | 2.74% |
| SM | -0.28% | $5.02B | +16.26% | 1.68% |
| ALGT | -0.30% | $1.30B | +5.00% | 1.70% |
| PFLT | -0.30% | - | - | 11.07% |
| QTTB | -0.33% | $354.34M | +188.64% | 0.00% |
| TCTM | -0.33% | $8.10M | -42.99% | 0.00% |
| CRGY | -0.36% | $2.32B | +24.43% | 3.35% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TPVG | -17.05% | $272.08M | - | 18.82% |
| WWW | -14.02% | $1.79B | +171.57% | 1.80% |
| FRSH | -11.51% | $4.39B | -20.05% | 0.00% |
| FARO | -10.78% | $486.17M | +40.51% | 0.00% |
| MNOV | -10.52% | $93.19M | +2.15% | 0.00% |
| TPST | -10.47% | $37.75M | -77.59% | 0.00% |
| AME | -10.33% | $44.75B | +24.49% | 0.56% |
| HUSA | -9.80% | $16.69M | -11.56% | 0.00% |
| SEG | -9.45% | $319.72M | +12.41% | 0.00% |
| MANU | -9.29% | $2.88B | -9.41% | 0.00% |
| LNG | -9.05% | $49.37B | +24.99% | 0.82% |
| BTCT | -9.03% | $42.61M | +353.33% | 0.00% |
| EOG | -8.85% | $76.03B | +10.19% | 2.70% |
| KNTK | -8.58% | $3.59B | +67.71% | 5.02% |
| VAC | -8.44% | $3.13B | +16.15% | 3.39% |
| KLG | -8.39% | $1.48B | +45.15% | 3.71% |
| STG | -8.12% | $35.67M | +7.92% | 0.00% |
| HIHO | -8.12% | $8.63M | 0.00% | 6.12% |
| KD | -8.08% | $6.51B | +55.09% | 0.00% |
| JBLU | -7.97% | $2.07B | +41.57% | 0.00% |
ETF's related to EOLS
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XPH | 32.05% | $157.87M | 0.35% |
| PINK | 29.98% | $161.15M | 0.5% |
| XBI | 29.41% | $6.58B | 0.35% |
| IHE | 29.31% | $596.23M | 0.39% |
| IWC | 29.06% | $933.99M | 0.6% |
| FDN | 28.18% | $6.98B | 0.51% |
| CLOU | 27.94% | $349.39M | 0.68% |
| AOM | 27.86% | $1.43B | 0.15% |
| JPMB | 27.81% | $585.28M | 0.39% |
| WCLD | 27.69% | $454.67M | 0.45% |
| XSW | 27.64% | $402.79M | 0.35% |
| PCY | 27.59% | $1.33B | 0.5% |
| XHE | 27.54% | $213.41M | 0.35% |
| PTH | 27.37% | $143.31M | 0.6% |
| EMB | 27.14% | $14.46B | 0.39% |
| PFF | 27.04% | $15.20B | 0.46% |
| SPFF | 27.02% | $151.50M | 0.48% |
| BSCW | 26.97% | $635.46M | 0.1% |
| EMHY | 26.92% | $448.75M | 0.5% |
| FINX | 26.90% | $332.34M | 0.68% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IEO | 0.08% | $658.25M | 0.4% |
| CMDY | 0.32% | $279.14M | 0.28% |
| SGOV | -0.39% | $27.53B | 0.09% |
| IVOL | 0.54% | $548.70M | 1.02% |
| MINT | -0.69% | $11.62B | 0.35% |
| DRLL | 0.84% | $336.91M | 0.41% |
| XLE | 0.96% | $37.90B | 0.09% |
| FTXN | 1.03% | $179.41M | 0.6% |
| BCI | -1.07% | $1.20B | 0.26% |
| BCD | 1.15% | $245.02M | 0.3% |
| FLTR | 1.33% | $1.79B | 0.14% |
| DBC | -1.45% | $1.39B | 0.87% |
| IBDP | 1.49% | $2.11B | 0.1% |
| JBBB | -1.53% | $1.26B | 0.49% |
| FENY | 1.53% | $1.64B | 0.084% |
| RSPG | 1.66% | $544.63M | 0.4% |
| COMT | -1.78% | $829.06M | 0.48% |
| IYE | 1.82% | $1.35B | 0.39% |
| VDE | 1.83% | $8.33B | 0.1% |
| DBMF | -1.97% | $1.02B | 0.85% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| DBA | -21.67% | $755.88M | 0.93% |
| SOYB | -16.90% | $27.32M | 0.22% |
| BTAL | -16.27% | $388.04M | 1.43% |
| USCI | -14.75% | $185.47M | 1.07% |
| UUP | -11.95% | $309.25M | 0.77% |
| TPMN | -10.89% | $40.60M | 0.65% |
| USDU | -10.61% | $201.97M | 0.5% |
| FTGC | -8.83% | $2.17B | 1.02% |
| CANE | -8.82% | $17.72M | 0.29% |
| VIXY | -7.40% | $195.31M | 0.85% |
| EQLS | -7.40% | $76.08M | 1% |
| UNG | -7.35% | $908.80M | 1.06% |
| CORN | -7.31% | $61.12M | 0.2% |
| KMLM | -4.76% | $353.87M | 0.9% |
| BSCO | -4.55% | $2.35B | 0.1% |
| DBO | -3.99% | $217.57M | 0.77% |
| DBE | -3.92% | $50.13M | 0.77% |
| CTA | -3.21% | $350.27M | 0.78% |
| GSG | -2.85% | $914.42M | 0.75% |
| PDBC | -2.14% | $4.40B | 0.59% |
News
Yahoo
Evolus (EOLS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Yahoo
Evolus (EOLS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Yahoo
The analysts might have been a bit too bullish on Evolus, Inc. ( NASDAQ:EOLS ), given that the company fell short of...
Yahoo
Evolus ( NASDAQ:EOLS ) Third Quarter 2024 Results Key Financial Results Revenue: US$61.1m (up 22% from 3Q 2023). Net...
Yahoo
Evolus Inc (EOLS) reports a 22% revenue increase, while navigating operating losses and market uncertainties.
Yahoo
Evolus (EOLS) delivered earnings and revenue surprises of -137.50% and 2.74%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.